127 related articles for article (PubMed ID: 17497319)
1. 15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls.
Fransson P; Widmark A
Acta Oncol; 2007; 46(4):517-24. PubMed ID: 17497319
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
Fransson P
Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
[TBL] [Abstract][Full Text] [Related]
3. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls.
Fransson P; Widmark A
Cancer; 1999 Feb; 85(3):678-88. PubMed ID: 10091741
[TBL] [Abstract][Full Text] [Related]
4. Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath technique.
Fransson P; Bergström P; Löfroth PO; Widmark A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):430-8. PubMed ID: 16904846
[TBL] [Abstract][Full Text] [Related]
5. Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls.
Fransson P; Widmark A
Urol Oncol; 2011; 29(2):137-44. PubMed ID: 19272798
[TBL] [Abstract][Full Text] [Related]
6. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life 10 years after external beam radiotherapy or watchful waiting in patients with localized prostate cancer.
Fransson P; Damber JE; Widmark A
Scand J Urol Nephrol; 2009; 43(2):119-26. PubMed ID: 18985545
[TBL] [Abstract][Full Text] [Related]
8. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.
Fransson P
Acta Oncol; 2005; 44(4):355-61. PubMed ID: 16120544
[TBL] [Abstract][Full Text] [Related]
9. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: a prospective assessment of acute and late treatment toxicity.
Wahlgren T; Nilsson S; Ryberg M; Lennernäs B; Brandberg Y
Acta Oncol; 2005; 44(6):633-43. PubMed ID: 16165923
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
13. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group.
Fransson P; Widmark A
Cancer; 1996 Sep; 78(5):1066-78. PubMed ID: 8780545
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
[TBL] [Abstract][Full Text] [Related]
15. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results.
Duchesne GM; Williams SG; Das R; Tai KH
Radiother Oncol; 2007 Aug; 84(2):128-34. PubMed ID: 17561293
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
Chen RC; Zhang Y; Chen MH; McMahon E; Loffredo M; McPherson CP; Nguyen AU; Nguyen PL; D'Amico AV
BJU Int; 2012 Dec; 110(11):1690-5. PubMed ID: 22502770
[TBL] [Abstract][Full Text] [Related]
17. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
18. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
19. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
